New COVID Shots Target JN.1 Variant: Who Needs Them?

Updated COVID-19 vaccines targeting the JN.1 variant are now available nationwide, arriving just as respiratory virus season begins in early September. These new monovalent vaccines are offered at major pharmacies, including CVS and Walgreens. While the Advisory Committee on Immunization Practices' role is under review, most insurance plans are expected to cover these shots at no cost, with a notable exception for Louisiana residents needing a prescription at CVS. Recommendations for the new COVID shot emphasize vulnerable groups. This includes adults aged 65 and older, and those under 65 with underlying medical conditions such as heart disease, lung disease, obesity, diabetes, or compromised immune systems. Pregnant individuals are also strongly advised to get vaccinated, as they face a higher risk of severe illness.

Children aged 6 months to 23 months are recommended to receive the vaccine, typically at a pediatrician's office. Children aged 2 to 18 with underlying conditions like asthma or cystic fibrosis should also be vaccinated. For healthy adults aged 19 to 64 without underlying conditions, vaccination is considered a more personal decision due to modest benefits and existing immunity, though it can still help protect others. Experts suggest getting the updated COVID shot in mid-to-late September or October to build protection before cases typically rise during colder months and holiday gatherings. For convenience, many recommend receiving it concurrently with the annual flu vaccine. Potential side effects are expected to be similar to previous COVID shots, including localized arm pain, fever, chills, and muscle aches, which are typically short-lived and manageable.